Advertisement
EYPT vs VTGN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Hold and VTGN is a Hold.
EYPT in +12.25% Uptrend, rising for three consecutive days on November 10, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where EYPT advanced for three days, in 238 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 63 cases where EYPT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on EYPT as a result. In 58 of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for EYPT just turned positive on November 02, 2026. Looking at past instances where EYPT's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.
EYPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EYPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for EYPT entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.187) is normal, around the industry mean (3.498). P/E Ratio (-0.096) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.380) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (101.010) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. EYPT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EYPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
VTGN's RSI Indicator climbs out of oversold territory
The RSI Indicator for VTGN moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In 35 of the 35 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 64 of 73 cases where VTGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on VTGN as a result. In 78 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
The Moving Average Convergence Divergence (MACD) for VTGN just turned positive on November 04, 2026. Looking at past instances where VTGN's MACD turned positive, the stock continued to rise in 38 of 41 cases over the following month. The odds of a continued upward trend are 90%.
Following a +10.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where VTGN advanced for three days, in 190 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
VTGN moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for VTGN crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for VTGN entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.297) is normal, around the industry mean (3.498). P/E Ratio (-0.099) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (3.764) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. VTGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VTGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
EYPT | VTGN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 2 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 62 Fair valued | 52 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 99 | |
PRICE GROWTH RATING 1..100 | 99 | 89 | |
P/E GROWTH RATING 1..100 | 5 | 15 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
VTGN's Valuation (52) in the Biotechnology industry is in the same range as EYPT (62) in the Pharmaceuticals Major industry. This means that VTGN’s stock grew similarly to EYPT’s over the last 12 months.
VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as EYPT (100) in the Pharmaceuticals Major industry. This means that VTGN’s stock grew similarly to EYPT’s over the last 12 months.
VTGN's SMR Rating (99) in the Biotechnology industry is in the same range as EYPT (99) in the Pharmaceuticals Major industry. This means that VTGN’s stock grew similarly to EYPT’s over the last 12 months.
VTGN's Price Growth Rating (89) in the Biotechnology industry is in the same range as EYPT (99) in the Pharmaceuticals Major industry. This means that VTGN’s stock grew similarly to EYPT’s over the last 12 months.
EYPT's P/E Growth Rating (5) in the Pharmaceuticals Major industry is in the same range as VTGN (15) in the Biotechnology industry. This means that EYPT’s stock grew similarly to VTGN’s over the last 12 months.
| EYPT | VTGN | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 78% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 88% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 86% |
| MACD ODDS (%) | 2 days ago 82% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 88% |
| Advances ODDS (%) | 2 days ago 83% | 8 days ago 79% |
| Declines ODDS (%) | 7 days ago 89% | 6 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 82% | N/A |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EYPT’s FA Score shows that 1 FA rating(s) are green while VTGN’s FA Score has 1 green FA rating(s).
- EYPT’s FA Score: 1 green, 4 red.
- VTGN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EYPT’s TA Score shows that 6 TA indicator(s) are bullish while VTGN’s TA Score has 5 bullish TA indicator(s).
- EYPT’s TA Score: 6 bullish, 2 bearish.
- VTGN’s TA Score: 5 bullish, 4 bearish.
Price Growth
EYPT (@Biotechnology) experienced а +1.05% price change this week, while VTGN (@Biotechnology) price change was +8.99% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
EYPT is expected to report earnings on Nov 12, 2026.
VTGN is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
EYPT and
Correlation & Price change
A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with ATHE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then ATHE could also see price increases.
| Ticker / NAME | Correlation To EYPT | 1D Price Change % | ||
|---|---|---|---|---|
| EYPT | 100% | +11.66% | ||
| ATHE - EYPT | 54% Loosely correlated | -4.53% | ||
| KROS - EYPT | 40% Loosely correlated | +1.74% | ||
| AMLX - EYPT | 38% Loosely correlated | +2.32% | ||
| KYTX - EYPT | 37% Loosely correlated | -1.74% | ||
| VTGN - EYPT | 37% Loosely correlated | -0.70% | ||
More | ||||
VTGN and
Correlation & Price change
A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with MENS. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then MENS could also see price increases.
| Ticker / NAME | Correlation To VTGN | 1D Price Change % | ||
|---|---|---|---|---|
| VTGN | 100% | -0.70% | ||
| MENS - VTGN | 59% Loosely correlated | -3.24% | ||
| UNCY - VTGN | 43% Loosely correlated | -1.08% | ||
| KYTX - VTGN | 39% Loosely correlated | -1.74% | ||
| REPL - VTGN | 38% Loosely correlated | +4.58% | ||
| SYRE - VTGN | 38% Loosely correlated | -4.15% | ||
More | ||||